24-Hour Glycemia: Rosiglitazone Versus Glimepiride In Type 2 Diabetes
NCT00318656
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
23
Enrollment
INDUSTRY
Sponsor class
Conditions
Non-Insulin-Dependent Diabetes Mellitus
Interventions
DRUG:
rosiglitazone-metformin fixed dose combination
DRUG:
metformin + glimepiride
Sponsor
GlaxoSmithKline